GENMARK DIAGNOSTICS INC's ticker is GNMK and the CUSIP is 372309104. A total of 105 filers reported holding GENMARK DIAGNOSTICS INC in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $92,000 | +64.3% | 3,881 | 0.0% | 0.00% | – |
| Q4 2020 | $56,000 | +1.8% | 3,881 | 0.0% | 0.00% | – |
| Q3 2020 | $55,000 | -3.5% | 3,881 | 0.0% | 0.00% | – |
| Q2 2020 | $57,000 | +256.2% | 3,881 | 0.0% | 0.00% | – |
| Q1 2020 | $16,000 | -11.1% | 3,881 | 0.0% | 0.00% | – |
| Q4 2019 | $18,000 | -61.7% | 3,881 | -46.9% | 0.00% | – |
| Q2 2019 | $47,000 | -9.6% | 7,315 | 0.0% | 0.00% | – |
| Q1 2019 | $52,000 | +52.9% | 7,315 | 0.0% | 0.00% | – |
| Q4 2018 | $34,000 | -37.0% | 7,315 | 0.0% | 0.00% | – |
| Q3 2018 | $54,000 | +14.9% | 7,315 | 0.0% | 0.00% | – |
| Q2 2018 | $47,000 | +17.5% | 7,315 | 0.0% | 0.00% | – |
| Q1 2018 | $40,000 | +33.3% | 7,315 | 0.0% | 0.00% | – |
| Q4 2017 | $30,000 | -55.9% | 7,315 | 0.0% | 0.00% | – |
| Q3 2017 | $68,000 | +183.3% | 7,315 | +265.8% | 0.00% | – |
| Q2 2017 | $24,000 | -7.7% | 2,000 | 0.0% | 0.00% | – |
| Q1 2017 | $26,000 | +4.0% | 2,000 | 0.0% | 0.00% | – |
| Q4 2016 | $25,000 | -88.1% | 2,000 | -88.8% | 0.00% | – |
| Q3 2016 | $210,000 | +172.7% | 17,800 | +100.0% | 0.00% | – |
| Q2 2016 | $77,000 | +63.8% | 8,900 | 0.0% | 0.00% | – |
| Q1 2016 | $47,000 | -31.9% | 8,900 | 0.0% | 0.00% | – |
| Q4 2015 | $69,000 | -1.4% | 8,900 | 0.0% | 0.00% | – |
| Q3 2015 | $70,000 | -12.5% | 8,900 | 0.0% | 0.00% | – |
| Q2 2015 | $80,000 | -30.4% | 8,900 | 0.0% | 0.00% | – |
| Q1 2015 | $115,000 | -5.0% | 8,900 | 0.0% | 0.00% | – |
| Q4 2014 | $121,000 | +51.2% | 8,900 | 0.0% | 0.00% | – |
| Q3 2014 | $80,000 | -33.3% | 8,900 | 0.0% | 0.00% | – |
| Q2 2014 | $120,000 | – | 8,900 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|